Showing 1 - 10 of 37
Persistent link: https://www.econbiz.de/10002160606
All developed countries have been struggling with a trend toward health care absorbing an ever-larger fraction of government and private budgets. Adopting any treatment that improves health outcomes, no matter what the cost, can worsen allocative inefficiency by paying dearly for small health...
Persistent link: https://www.econbiz.de/10013225017
We use the design of Medicare’s prescription drug benefit program to demonstrate three facts about the health consequences of cost-sharing. First, we show that an as-if-random increase of 33.6% in out-of-pocket price (11.0 percentage points (p.p.) change in coinsurance, or $10.40 per drug)...
Persistent link: https://www.econbiz.de/10013240384
In the United States, two patients with the same medical condition can receive drastically different treatments. In addition, the same patient can walk into two physicians’ offices and receive equally disparate treatments. This chapter attempts to understand why. It focuses on three areas: the...
Persistent link: https://www.econbiz.de/10014025582
Why have health care costs moderated in the last decade? Some have suggested the Great Recession alone was the cause, but health expenditure growth in the depths of the recession was nearly identical to growth prior to the recession. Nor can the Affordable Care Act (ACA) can take credit, since...
Persistent link: https://www.econbiz.de/10013061817
In the United States, health care technology has contributed to rising survival rates, yet health care spending relative to GDP has also grown more rapidly than in any other country. We develop a model of patient demand and supplier behavior to explain these parallel trends in technology growth...
Persistent link: https://www.econbiz.de/10013127016
Persistent link: https://www.econbiz.de/10009156976
Persistent link: https://www.econbiz.de/10009006777
Persistent link: https://www.econbiz.de/10010227407
Persistent link: https://www.econbiz.de/10009724876